The correlation of RANK, RANKL and TNFα expression with bone loss volume and polyethylene wear debris around hip implants

被引:105
作者
Holding, Christopher A.
Findlay, David M.
Stamenkov, Roumen
Neale, Susan D.
Lucas, Helen
Dharmapatni, A. S. S. K.
Callary, Stuart A.
Shrestha, Kush R.
Atkins, Gerald J.
Howie, Donald W.
Haynes, David R. [1 ]
机构
[1] Univ Adelaide, Dept Pathol, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Dept Orthopaed & Trauma, Adelaide, SA 5000, Australia
[3] Hanson Inst, Adelaide, SA 5000, Australia
基金
英国医学研究理事会;
关键词
osteolysis; osteoclast; wear debris; polyethylene; image analysis;
D O I
10.1016/j.biomaterials.2006.05.054
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
This study investigates receptor activator NF-kappa B (RANK), RANK ligand (RANKL) and tumour necrosis factor (TNF alpha), key factors regulating bone turnover, present in the tissues near peri-prosthetic osteolysis. Tissue was obtained from zones of peri-prosthetic osteolysis from 11 patients undergoing revision of total hip prostheses, analysed preoperatively by high-resolution spiral multislice CT using a metal artefact suppression protocol. Synovial tissue from 10 patients with osteoarthritis undergoing primary hip replacement was used as control tissue. Immunohistochemical analysis of formalin fixed tissue sections demonstrated that RANK, RANKL and TNFa were strongly expressed by large multinucleated cells containing polyethylene wear debris in revision tissues. Control tissue stained weakly for RANK, RANKL and TNFa. A strong statistical correlation (p < 0.02) was found between the five parameters, volume of bone loss, polyethylene wear debris, RANK, RANKL and TNFa expression. Importantly, in vitro studies revealed that RANKL and TNF alpha synergise to increase the volume of bone resorbed, by more than seven fold, when compared to the effect of either cytokine treatment alone. This suggests that the interaction of TNFa and RANKL promotes osteoclast activity associated with polyethylene wear and therapies targeting TNF activity may be useful to treat peri-implant osteolysis. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5212 / 5219
页数:8
相关论文
共 36 条
[1]  
ALSAFFAR N, 1994, BRIT J RHEUMATOL, V33, P309
[2]   A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[3]   Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA [J].
Baumann, B ;
Rader, CP ;
Seufert, J ;
Nöth, U ;
Rolf, O ;
Eulert, J ;
Jakob, F .
ACTA ORTHOPAEDICA SCANDINAVICA, 2004, 75 (03) :295-302
[4]   The effects of the concentration of high-density polyethylene particles on the bone-implant interface [J].
Brooks, RA ;
Sharpe, JR ;
Wimhurst, JA ;
Myer, BJ ;
Dawes, EN ;
Rushton, N .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2000, 82B (04) :595-600
[5]   Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss:: expression of receptor activator NFκB, RANK ligand and osteoprotegerin [J].
Crotti, TN ;
Smith, MD ;
Findlay, DM ;
Zreiqat, H ;
Ahern, MJ ;
Weedon, H ;
Hatzinikolous, G ;
Capone, M ;
Holding, C ;
Haynes, DR .
BIOMATERIALS, 2004, 25 (04) :565-573
[6]   RANK ligand and TNF-α mediate acid-induced bone calcium efflux in vitro [J].
Frick, KK ;
LaPlante, K ;
Bushinsky, DA .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2005, 289 (05) :F1005-F1011
[7]   TNFa potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL [J].
Fuller, K ;
Murphy, C ;
Kirstein, B ;
Fox, SW ;
Chambers, TJ .
ENDOCRINOLOGY, 2002, 143 (03) :1108-1118
[8]   Gene expression clustering using self-organizing maps: analysis of the macrophage response to particulate biomaterials [J].
Garrigues, GE ;
Cho, DR ;
Rubash, HE ;
Goldring, SR ;
Herndon, JH ;
Shanbhag, AS .
BIOMATERIALS, 2005, 26 (16) :2933-2945
[9]  
GRAVES SE, 2004, MED J AUSTRALIA, V180, P531
[10]  
Hansen T, 2001, J RHEUMATOL, V28, P1615